Overview


According to FutureWise analysis the market for veterinary immunodiagnostics in 2023 is US$ 1.57 billion, and is expected to reach US$ 3.24 billion by 2031 at a CAGR of 9.50%.

Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth.
  • Abaxisincl
  • bioMérieux SA
  • IDEXX Laboratories Inc.
  • Heska Corporation
  • Virbac SA
  • Zoetis inc.
  • Randox Laboratories Ltd.
  • Neogen Corporation
  • Woodley Equipment Company Ltd
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Analyzers
  • Consumables

By Animal Type

  • Livestock
    • Cattle
    • Pigs
    • Poultry
    • Others
  • Companion
    • Feline
    • Canine
    • Equine
    • Others

By Technology

  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Chemiluminescence Immunoassay
    • Fluorescent Immunoassay
    • Colorimetric Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Others

By Application

  • Infectious Disease
  • Autoimmune Disorder
  • Endocrinology Oncology
  • Bone and Mineral diseases
  • Others

By End User

  • Reference Laboratories
  • Academic and Research Institutes
  • Veterinary Hospitalsand Clinics
  • Point of care/ In-house testing

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Global Veterinary Immunodiagnostics Market By Product Type, By Animal Type, By Technology, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Veterinary Immunodiagnostics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Veterinary Immunodiagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Veterinary Immunodiagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Veterinary Immunodiagnostics Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Analyzers
        2. Consumables

  • 8.   Veterinary Immunodiagnostics Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Livestock
         1.1. Cattle
         1.2. Pigs
         1.3. Poultry
         1.4. Others
        2. Companion
         2.1. Feline
         2.2. Canine
         2.3. Equine
         2.4. Others

  • 9.   Veterinary Immunodiagnostics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Enzyme-Linked Immunosorbent Assay (ELISA)
         1.1. Chemiluminescence Immunoassay
         1.2. Fluorescent Immunoassay
         1.3. Colorimetric Immunoassay
        2. Radioimmunoassay
        3. Rapid Test
        4. Others

  • 10.   Veterinary Immunodiagnostics Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Infectious Disease
        2. Autoimmune Disorder
        3. Endocrinology and Oncology
        4. Bone and Mineral Diseases
        5. Others

  • 11.   Veterinary Immunodiagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Reference Laboratories
        2. Academic and Research Institutes
        3. Veterinary Hospitals and Clinics
        4. Point of Care/ In-house Testing

  • 12.   North America Veterinary Immunodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Veterinary Immunodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Veterinary Immunodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Veterinary Immunodiagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abaxisincl
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. bioMérieux SA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. IDEXX Laboratories Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Heska Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Virbac SA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Zoetis inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Randox Laboratories Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Neogen Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Woodley Equipment Company Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Thermo Fisher Scientific Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.QIAGEN N.V
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11